CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-11 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 92,271 | ||
| 2026-03-11 | PISKEL KYLE Chief Financial Officer | Sale | −18,672 | $13.17 | $246K | 259,840 |
| 2026-03-11 | LO FRANCIS Chief People Officer | Sale 10b5-1 | −30,593 | $14.08 | $431K | 291,374 |
| 2026-03-11 | ROBINS CHAD M CEO and Chairman | Sale | −140,567 | $13.17 | $1.9M | 2,630,713 |
| 2026-03-11 | ROBINS CHAD M CEO and Chairman | Sale | −329,600 | $13.17 | $4.3M | 2,301,113 |
| 2026-03-11 | GRIFFIN MICHELLE RENEE Director | Sale | −15,394 | $13.91 | $214K | 15,625 |
| 2026-03-10 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $6.55 | $96K | 662,531 |
| 2026-03-10 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +400 | $12.14 | $5K | 662,931 |
| 2026-03-10 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,460 | $14.68 | $286K | 643,471 |
| 2026-03-10 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 106,993 | ||
| 2026-03-10 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −400 | 403,539 | ||
| 2026-03-09 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $6.55 | $96K | 666,869 |
| 2026-03-09 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 678,750 |
| 2026-03-09 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −30,941 | $14.79 | $458K | 647,809 |
| 2026-03-09 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 121,715 | ||
| 2026-03-09 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 403,939 | ||
| 2026-03-06 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $6.55 | $96K | 671,207 |
| 2026-03-06 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 683,088 |
| 2026-03-06 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −30,941 | $15.14 | $468K | 652,147 |
| 2026-03-06 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 136,437 |
Page 18 of 119 · 2,375 trades